Cargando…

The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohort

In order to systematically describe the Parkinson’s disease phenome, we performed a series of 832 cross-sectional case-control analyses in a large database. Responses to 832 online survey-based phenotypes including diseases, medications, and environmental exposures were analyzed in 23andMe research...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heilbron, Karl, Noyce, Alastair J., Fontanillas, Pierre, Alipanahi, Babak, Nalls, Mike A., Cannon, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437217/ https://www.ncbi.nlm.nih.gov/pubmed/30937360 http://dx.doi.org/10.1038/s41531-019-0077-5

Ejemplares similares

Unhealthy Behaviours and Risk of Parkinson’s Disease: A Mendelian Randomisation Study
por: Heilbron, Karl, et al.
Publicado: (2021)

Mendelian Randomization — the Key to Understanding Aspects of Parkinson's Disease Causation?
por: Noyce, Alastair J., et al.
Publicado: (2015)

Bidirectional relationship between olfaction and Parkinson’s disease
por: Kim, Jonggeol J., et al.
Publicado: (2023)

Evaluating Lipid‐Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization
por: Williams, Dylan M., et al.
Publicado: (2020)

Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank
por: Jacobs, Benjamin Meir, et al.
Publicado: (2020)

Analysis of rare Parkinson’s disease variants in millions of people
por: Pitz, Vanessa, et al.
Publicado: (2023)

The Parkinson's Disease Mendelian Randomization Research Portal
por: Noyce, Alastair J., et al.
Publicado: (2019)

The prodromes of Parkinson's disease
por: Rees, Richard Nathaniel, et al.
Publicado: (2018)

Domotics, Smart Homes, and Parkinson’s Disease
por: Simonet, Cristina, et al.
Publicado: (2021)

The prediagnostic phase of Parkinson's disease
por: Noyce, Alastair John, et al.
Publicado: (2016)

Infection and Risk of Parkinson’s Disease
por: Smeyne, Richard J., et al.
Publicado: (2021)

Technologies Assessing Limb Bradykinesia in Parkinson’s Disease
por: Hasan, Hasan, et al.
Publicado: (2017)

Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors
por: Liu, Hui, et al.
Publicado: (2022)

Genetic prediction of impulse control disorders in Parkinson's disease
por: Weintraub, Daniel, et al.
Publicado: (2022)

Mendelian Randomization Study Shows No Causal Relationship Between Circulating Urate Levels and Parkinson’s Disease
por: Kia, Demis A., et al.
Publicado: (2018)

Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts
por: Dadu, Anant, et al.
Publicado: (2022)

An early diagnosis is not the same as a timely diagnosis of Parkinson's disease
por: Rees, Richard Nathaniel, et al.
Publicado: (2018)

Ethnic Variation in the Manifestation of Parkinson’s Disease: A Narrative Review
por: Ben-Joseph, Aaron, et al.
Publicado: (2020)

Gender Differences in the Prevalence of Parkinson's Disease
por: Zirra, Alexandra, et al.
Publicado: (2022)

The Association Between Type 2 Diabetes Mellitus and Parkinson’s Disease
por: Cheong, Julia L.Y., et al.
Publicado: (2020)

Predicting diagnosis of Parkinson's disease: A risk algorithm based on primary care presentations
por: Schrag, Anette, et al.
Publicado: (2019)

Phenome-based gene discovery provides information about Parkinson’s disease drug targets
por: Chen, Yang, et al.
Publicado: (2016)

Crop Seed Phenomics: Focus on Non-Destructive Functional Trait Phenotyping Methods and Applications
por: Hacisalihoglu, Gokhan, et al.
Publicado: (2023)

The broad impact of cell death genes on the human disease phenome
por: Rich, Abigail, et al.
Publicado: (2023)

A service development study of the assessment and management of fracture risk in Parkinson’s disease
por: Shribman, Samuel, et al.
Publicado: (2014)

Lower Lymphocyte Count is Associated With Increased Risk of Parkinson’s Disease
por: Jensen, Melanie P., et al.
Publicado: (2021)

Integrating phenotype ontologies with PhenomeNET
por: Rodríguez-García, Miguel Ángel, et al.
Publicado: (2017)

Bone health in Parkinson's disease: a systematic review and meta-analysis
por: Torsney, Kelli M, et al.
Publicado: (2014)

Disease risk scores for skin cancers
por: Fontanillas, Pierre, et al.
Publicado: (2021)

The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
por: Bloem, B. R., et al.
Publicado: (2019)

Genome–phenome wide association study of broadly defined headache
por: Hsu, Wan-Ting, et al.
Publicado: (2023)

Meta-Analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease
por: Noyce, Alastair J, et al.
Publicado: (2012)

Application of a Simple Parkinson's Disease Risk Score in a Longitudinal Population‐Based Cohort
por: Marini, Kathrin, et al.
Publicado: (2020)

Deep Phenotyping of Parkinson’s Disease
por: Dorsey, E. Ray, et al.
Publicado: (2020)

Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study
por: Noyce, Alastair J., et al.
Publicado: (2017)

Research into biomarkers to facilitate the early identification of Parkinson's disease: a decision analytic model to determine the feasibility and value
por: Hunter, Rachael, et al.
Publicado: (2013)

Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study
por: Kang, Xiaoying, et al.
Publicado: (2021)

Type 2 Diabetes as a Determinant of Parkinson’s Disease Risk and Progression
por: Chohan, Harneek, et al.
Publicado: (2021)

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts
por: Iwaki, Hirotaka, et al.
Publicado: (2019)

Effect Modification between Genes and Environment and Parkinson's Disease Risk
por: Periñán, Maria Teresa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hrovvvb4dtntu0790bhrkg2n7p